Driehaus Small Cap Growth Investor holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
Driehaus Small Cap Growth Fund Investor Class DVSMX
- NAV / 1-Day Return 28.63 / +0.49 %
- Total Assets 1.6B
-
Adj. Expense Ratio
0.930%
- Expense Ratio 0.910%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Limited
- TTM Yield 0.20%
- Turnover 152%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:22 AM GMT+0
Morningstar’s Analysis DVSMX
Will DVSMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Northern Institutional US Govt Sel | 2.63 | 41M | Cash and Equivalents |
Guardant Health Inc | 2.40 | 37M | Healthcare |
Spyre Therapeutics Inc | 2.11 | 33M | Healthcare |
Crinetics Pharmaceuticals Inc | 1.83 | 28M | Healthcare |
Praxis Precision Medicines Inc Ordinary Shares | 1.80 | 28M | Healthcare |
Definium Therapeutics Inc Ordinary Shares | 1.79 | 28M | Healthcare |
Xenon Pharmaceuticals Inc | 1.61 | 25M | Healthcare |
Curtiss-Wright Corp | 1.59 | 25M | Industrials |
Edgewise Therapeutics Inc | 1.39 | 22M | Healthcare |
Twist Bioscience Corp | 1.37 | 21M | Healthcare |